[1] 杨期东. 神经病学[M]. 北京: 人民卫生出版社, 2002:118-152.
[2] Audebert HJ, Pellkofer TS, Wimmer ML, et al. Progression in lacunar stroke is related to elevated acute phase parameters[J].Eur Neurol,2004,51(3):125-131.
[3] 高丽霞,卢丽萍,杜小鹏,等.缺血性进展性卒中危险因素临床探讨[J].实用神经疾病杂志,2005,8(2):24.
[4] 陈兴洲,李宏健,陈兵勋.恶化性卒中[J].国外医学:脑血管疾病分册,2000,8(2):109.
[5] Nicolas V,Jose C,Antonio D,et al.Proinflammatory cytokines and early neurological worsening in ischemic stroke[J].Stroke,2000,31(4):2325.
[6] 张洪,梅元武,孙圣刚,等.脑缺血与高温关系的研究进展[J].中华神经科杂志,2000,33(5):305.
[7] Jorgensen HS,Nakayama H,Olsen TS,et al.Effect of blood pressure and diabetes on stroke in progression[J].Lancet,1994,344(8916):156-159.
[8] Right FW,Barber M,Stott DJ,et al.Predictors of stroke in progression [J].A case control study Oxford University Press,2003,32(1):8.
[9] 高建国,周农,翟金霞,等.血清C反应蛋白水平与脑梗死预后的关系[J].临床神经病学杂志,2005,18(1):43-44.
[10] 王爱民,周颖,肖波,等.脑梗死患者血清高敏C反应蛋白水平的变化及临床意义[J].临床神经病学杂志,2005,18(2):153-154.
[11] 李雪梅,刘美萍,刘百波,等.血清超敏C反应蛋白与老年急性缺血性脑卒中的关系[J].中风与神经疾病杂志,2005,22(3):208.
[12] 曹红,孙长凯,赵杰,等.他汀类药物对脑梗死患者血清C反应蛋白的影响及其临床意义[J].中华神经科杂志,2005,38(5):329-330.
[13] Yasojima K,Schwab C,MeGeer EG,et al.Generation of C-reactive protein and complement components in atherosclerotic plaques [J].Am J Pathol,2001,158(6):1039-1051.
[14] Brasier AR,Recinos A,Eledrisi MS.Vascular inflammation and renninangiotensin system [J].Arterioscler Thromb Vase Biol,2002,22(3):1257-1266.
[15] Rost NS,Wolf PA.Kase CS,et al.Plasma concentration of C-reactive protein and risk of ischemia stroke and transient ischemic attack:the Framingham study[J].Stroke,2000,31(1):278-279.
[16] Di Napoli M,Papa F.Clinical application of Creactive protein in stroke prevention:bright and dark sides of the moon[J].Expert Rev Neurother,2004,4(4):613-622.
[17] 曲东锋,陈必洲,李宏建,等.缺血性卒中患者的早期处理指南[J].国外医学:脑血管疾病分册,2003,11(5):323-329.
[18] Lyign I,Bakirci Y.Plasma conentration of creactive proteinand fibrinogen in ischaemic stroke[J].Int Med Res,2002,30(6):591-596.